NeuroSense reports 65% death risk reduction in ALS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. SPY
6. FN
7. KLAR
8. METC
9. WEAV
10. TSLA

Go back to NeuroSense reports 65% death risk reduction in ALS trial
(NASDAQ: NRSN) Delayed: 0.41 -0.02 (4.65%)
Previous Close $0.43    52 Week High $ 
Open $0.43    52 Week Low $ 
Day High $0.43    P/E N/A 
Day Low $0.39    EPS $ 
Volume 193,654       

(NASDAQ: NRSNW) Delayed: 0.08 --0 (-0%)
Previous Close $0.08    52 Week High $ 
Open $0.08    52 Week Low $ 
Day High $0.08    P/E N/A 
Day Low $0.08    EPS $ 
Volume 7